MarketWatch - Stock Market Quotes, Business News, Financial News
Bulletin
Investor Alert
need to know
Kohl's tells 3 top execs their positions are cut
Pope Francis in Cuba for historic meeting
Shake Shack plans to open in St. Louis
Zika vaccine is at least a year and a half away
10 big stories you’ve missed this week
Penney responds to lawsuit over Burberry plaid
Mattel names new boss for Barbie business

It’s a ‘new Cold War,’ warns Russia PM

Bank of America chief gets a 23% pay raise
Intel lured Qualcomm exec with $25 mln pay
CEO Jamie Dimon’s $26 mln bet on J.P. Morgan

I want my disabled sister out of our family home

Google exec squirms when questioned about pay

ECB may finally deal a deathblow to the €500 bill
Yen has crossed a ‘line in the sand’
Time for a coordinated response to the yuan?
Dollar to hit ¥95 by end of the year: Barclays

This can’t be why Apple made Beats deal with Dre

5 things to know about the Costco and AmEx breakup

How grocery business got ‘barbell’ shape

Dispute over safety claims costs Uber $28.5 mln

What bear market? Stocks look likely to rise

5 signs we might already be in a bear market
Looks like time for bottom fishing in stocks

Grammys make Memphis candy shop a winner

Economists increasingly see Fed hands as tied
What central-bank failures mean for investors
Have central banks lost market credibility?

How I paid off my student loans early

College freshmen most liberal since Vietnam

Big banks are fleeing the mortgage market
Big banks are fleeing the mortgage market
Boomers are loading up on debt, not millennials

Why you probably won’t see 99 cent gas

Taxpayers already paying for future Super Bowls

Beer’s incessant infighting clouds the big picture

How to buy a used car
The correct way to go about buying a used car

Don’t get smoked by your marijuana investment

Actually, the most popular new emoji isn’t the taco
/conga/frontpage.html 367881

Markets »

132.55MDow Volume:
Avg Vol: 132.70M
Unchanged
134
Decliners
1500
Advancers
4873
Price Chg %Chg 1 Day
Range: 1 Day
  • 1 Day
  • 5 Days
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 2 Years
Dow
/quotes/zigman/627449/realtime 15,974 +314 2.00%
Nasdaq
/quotes/zigman/12633936/realtime 4,338 +71 1.66%
S&P 500
/quotes/zigman/3870025/realtime 1,865 +36 1.95%
GlobalDow
/quotes/zigman/629063/realtime 2,070 +23 1.11%
Gold
/quotes/zigman/33772884/delayed 1,239 -9 0.75%
Oil
/quotes/zigman/2260836/delayed 29.02 +2.81 10.72%
FTSE 100
/quotes/zigman/3173262/delayed 5,708 +171 3.08%
DAX
/quotes/zigman/2380246/delayed 8,968 +215 2.45%
CAC 40
/quotes/zigman/3173214/delayed 3,995 +98 2.52%
FTSE MIB
/quotes/zigman/1482176/delayed 16,515 +742 4.70%
IBEX 35
/quotes/zigman/2759620/delayed 7,921 +175 2.25%
Stoxx 600
/quotes/zigman/2380150/delayed 312 +9 2.91%
Asia Dow
/quotes/zigman/6959860/realtime 2,385 -51 2.10%
Nikkei 225
/quotes/zigman/5986735/delayed 14,953 -761 4.84%
Hang Seng
/quotes/zigman/2622475/delayed 18,320 -226 1.22%
Shanghai
/quotes/zigman/1859015/delayed 2,763 -18 0.63%
Sensex
/quotes/zigman/1652085/delayed 22,986 +34 0.15%
Singapore
/quotes/zigman/1709939/delayed 2,540 +2 0.07%
Euro
/quotes/zigman/16008136/realtime/sampled 1.13 -0.01 0.61%
Yen
/quotes/zigman/16008150/realtime/sampled 113.25 +0.83 0.74%
Pound
/quotes/zigman/16008140/realtime/sampled 1.45 +0.00 0.18%
Australia$
/quotes/zigman/16008115/realtime/sampled 0.71 0.00 0.04%
DXY Index
/quotes/zigman/1652083/delayed 95.97 +0.36 0.38%
WSJ $ Idx
/quotes/zigman/41508961/realtime 88.99 +0.23 0.26%
U.S. 10yr
/quotes/zigman/15866666/realtime 1.75 0.00 0.00%
German 10y
/quotes/zigman/15866409/realtime 0.26 +0.07 37.97%
Italy 10yr
/quotes/zigman/15866497/realtime 1.64 -0.08 4.67%
Spain 10yr
/quotes/zigman/15866444/realtime 1.74 -0.04 2.01%
U.K. 10yr
/quotes/zigman/15866328/realtime 1.42 0.00 0.00%
Japan 10yr
/quotes/zigman/15866525/realtime 0.08 +0.06 442.45%
Crude Oil
/quotes/zigman/2260836/delayed 29 +3 10.72%
Gold
/quotes/zigman/33772884/delayed 1,239 -9 0.75%
Corn
/quotes/zigman/25518691/delayed 359 -1 0.35%
DJIA F
/quotes/zigman/48241424/delayed 15,925 +313 2.00%
S&P F
/quotes/zigman/43106711/delayed 1,860 +36 1.95%
Silver
/quotes/zigman/32655632/delayed 16 0 0.03%

Quotes

Symbol Price Change % Change
FB /quotes/zigman/9962609/composite 102.01 0.10 0.10%
AAPL /quotes/zigman/68270/composite 93.99 0.29 0.31%
GOOG /quotes/zigman/59527964/composite 682.40 -0.71 -0.10%
BAC /quotes/zigman/190927/composite 11.95 0.79 7.08%
C /quotes/zigman/5065548/composite 37.54 2.56 7.32%
F /quotes/zigman/264304/composite 11.55 0.38 3.40%
T /quotes/zigman/398198/composite 36.47 0.26 0.72%
BP /quotes/zigman/247026/composite 29.02 1.38 4.99%
GE /quotes/zigman/227468/composite 28.26 0.81 2.95%
Visit the quote page and your most recently viewed stocks will automatically be displayed here.
Please log in to view your watchlist
MarketWatch Portfolio

World News from MarketWatch

Rates »

5 yr CD
1.3%
2 yr CD
0.7%
1 yr CD
0.6%
MMA $10K+
0.2%
MMA $50K+
0.4%

National averages from Bankrate.com

You Don’t Need Another Credit Card, You Need A Better One.
Avg. APR Last Week 6 Months
Low Interest 11.96% 11.96% 11.62%
Business 13.12% 13.12% 12.85%
Student 13.42% 13.42% 13.14%
Balance Transfer 14.35% 14.35% 14.12%
Airline 15.17% 15.17% 15.10%
Cash Back 15.20% 15.26% 15.27%
Reward 15.25% 15.28% 15.14%
Instant Approval 18.02% 18.21% 18.00%
Bad Credit 22.56% 22.88% 22.73%
Source:CreditCards.com

SPONSORED SECTIONS

Trending Tickers
  • /quotes/zigman/259867/composite RAX+5.19%
  • /quotes/zigman/69765/composite CERN+1.76%
  • /quotes/zigman/333256/composite IYT+2.39%
  • /quotes/zigman/4475302/composite HII+2.23%
  • /quotes/zigman/20919077/composite INDL+3.17%
X
Powered by StockTwits
Link to MarketWatch's Slice.

As of July 2, 2013, the SmartMoney content you loved now lives on MarketWatch.

MarketWatch will continue to provide the same important news and information you rely on every day. And, as a MarketWatch user, you will be able to enjoy:

  • Personalized news and quote email alerts
  • Editorial e-newsletters about personal finance, mutual funds and market-specific coverage
  • Premium newsletters by our market experts
  • Games, such as Virtual Stock Exchange and Beat the Darts
  • Free WSJ.com registration

SmartMoney Blogs

Real-Time Advice
Our real-time advice on how market shifts and news impact you and your money

Investing in ‘Junk DNA’

Now that scientists have revealed that the huge swaths of genetic code once dismissed as “junk DNA” are not so worthless, investors may wonder if there’s similar hidden value in the biotech sector. The short answer: maybe.

Alexander Raths / Shutterstock.com

Though analysts say it’s too soon to tell what impact the discovery will have on stocks, the recent breakthrough may eventually lead to new techniques for the early detection of diseases and to the development of new drugs. And that could be a boon to firms at the forefront of biotechnology and molecular diagnostics.

Even before the findings from the project known as Encode emerged, the biotechnology sector was already on the cutting edge, at least in terms of market performance: The iShares Nasdaq Biotechnology Index ETF (IBB) is up more than 47% over the past 12 months, with double the returns of the broader S&P Healthcare Index. But this latest discovery suggests there could be even more promising returns ahead. The new understanding of junk DNA may help science-driven pharmaceutical companies figure out which genetic proteins can be treated with drugs, lead diagnostics companies to which genetic variations are red flags for certain diseases and help other firms evaluate the effectiveness of their treatments, says Dr. Thomas Gingeras, the head of functional genomics at Cold Spring Harbor Laboratory and one of the principal investigators for the Encode project.

“This junk DNA is just another layer of complexity, but it also brings us a little bit closer to having a more full set of therapies that we can bring to patients,” says Karen Andersen, a Morningstar biotechnology analyst.

It wouldn’t be the first time that what scientists once considered genetic trash turned into corporate treasure. Regulus Therapeutics, a joint venture between drug companies Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals (ISIS) that last month began SEC proceedings to go public, focuses entirely on treating diseases through microRNA—but a decade ago, that part of the genome was also considered junk. (Regulus declined to comment.)

The new research may also bring business to Alnylam, which uses a technique known as RNA Interference to basically turn off disease-causing genes; the data could help the company identify new disease markers for which it could develop therapies, says Barry Greene, Alnylam’s chief operating officer. “It opens up a world of biologic insight that will be helpful,” says Greene. While it may take a while for companies to apply the results, the research is a step forward that might eventually lead to companies like Regulus being formed to pursue new genetic therapies: “We’ve never written aspects of the genome off,” Greene says.

The new insight may also have positive implications for molecular diagnostics companies that are already using genomic information to test for diseases, such as Myriad Genetics (MYGN), which makes tests for evaluating how likely a person is to develop various types of cancer. Knowing more about the “junk DNA” might help the company develop more sophisticated tests to detect a disease even before it forms, says Andersen. Myriad declined to comment.

Pharmaceutical companies are also increasingly interested in harnessing our genes to create better drugs and to assess whether those drugs will work for a patient or cause side effects. A large part of the strategy at Roche (RHHBY), for example, is genetic research, which the company uses to create diagnostic tests to go along with each of its drugs, in an effort to deliver more “personalized health care.” Sixty percent of the drugs in the firm’s pipeline are now paired with a test, including treatments it is developing for schizophrenia and Alzheimer’s disease. Roche was not available to comment before press time.

Another type of genetic science known as epigenetics—which relates to how a gene is expressed—is becoming popular with pharmaceutical companies, who are using the concept to create new drugs that can virtually alter a person’s genetic instructions, says Andersen. Celgene (CELG), for one, racked up about $700 million last year in sales of its drug Vidaza, which treats some forms of anemia and leukemia by helping bone marrow produce normal blood cells instead of unhealthy ones.

Celgene executives weren’t available to comment on Encode’s implications for the company, but a spokesman said that the biotechnology industry is experiencing “a shift toward targeted therapies” such as epigenetics, and that greater understanding of genetic and cellular functions helps researchers “narrow their focus within diseases themselves” and “uncover new pathways that may lead to whole classes of therapies.”

Comments

We welcome thoughtful comments from readers. Please comply with our guidelines. Our blogs do not require the use of your real name.

Comments (5 of 11)

View all Comments »
    • En jevn bevegelse inn og ut kan gradvis tilvenne rumpa størrelsen, og så kan du øke på med noe større. Det er kun den seksuelle opplevelsen som teller og står i fokus. Til temaet er sex mulighetene mange og man kan utforske mye.

    • Det er lettest om han som er i rumpa ikke beveger seg så mye. Jeg har mine forestillinger om hva jeg leter etter og det er modne damer som er åpen for Swinger. Fokuset her er ikke på den raske, anonyme og overfladiske tilfredsstillelsen, men på et spennende møte mellom to mennesker som ønsker å dele singelsex erfaringer med hverandre.

    • Hello! I could have sworn I’ve been to this site before but after reading through some of the post I realized it’s new to me. Anyhow, I’m definitely glad I found it and I’ll be book-marking and checking back often!

    • Det er jo noen som syns det er ekkelt å ha sex i det fri og mange er redd for at det er noen som tar dem på fersken. Det er kun den seksuelle opplevelsen som teller og står i fokus. De vakre og unge menneskene fra reklamen blir ikke lenger sett på som en trussel.

    • Excellently)))))))

      _________________

      Everything You Wanted To Know About Coupons Answered Here

About Real-Time Advice

  • How breaking news — in the markets, Washington, and around the world — affects you and your money. Have a question about how current events may change your financial future? Email us at ask@smartmoney.com.

MarketWatch - Stock Market Quotes, Business News, Financial News
Bulletin
Investor Alert
need to know
Kohl's tells 3 top execs their positions are cut
Pope Francis in Cuba for historic meeting
Shake Shack plans to open in St. Louis
Zika vaccine is at least a year and a half away
10 big stories you’ve missed this week
Penney responds to lawsuit over Burberry plaid
Mattel names new boss for Barbie business

It’s a ‘new Cold War,’ warns Russia PM

Bank of America chief gets a 23% pay raise
Intel lured Qualcomm exec with $25 mln pay
CEO Jamie Dimon’s $26 mln bet on J.P. Morgan

I want my disabled sister out of our family home

Google exec squirms when questioned about pay

ECB may finally deal a deathblow to the €500 bill
Yen has crossed a ‘line in the sand’
Time for a coordinated response to the yuan?
Dollar to hit ¥95 by end of the year: Barclays

This can’t be why Apple made Beats deal with Dre

5 things to know about the Costco and AmEx breakup

How grocery business got ‘barbell’ shape

Dispute over safety claims costs Uber $28.5 mln

What bear market? Stocks look likely to rise

5 signs we might already be in a bear market
Looks like time for bottom fishing in stocks

Grammys make Memphis candy shop a winner

Economists increasingly see Fed hands as tied
What central-bank failures mean for investors
Have central banks lost market credibility?

How I paid off my student loans early

College freshmen most liberal since Vietnam

Big banks are fleeing the mortgage market
Big banks are fleeing the mortgage market
Boomers are loading up on debt, not millennials

Why you probably won’t see 99 cent gas

Taxpayers already paying for future Super Bowls

Beer’s incessant infighting clouds the big picture

How to buy a used car
The correct way to go about buying a used car

Don’t get smoked by your marijuana investment

Actually, the most popular new emoji isn’t the taco
/conga/frontpage.html 367881

Markets »

132.55MDow Volume:
Avg Vol: 132.70M
Unchanged
134
Decliners
1500
Advancers
4873
Price Chg %Chg 1 Day
Range: 1 Day
  • 1 Day
  • 5 Days
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 2 Years
Dow
/quotes/zigman/627449/realtime 15,974 +314 2.00%
Nasdaq
/quotes/zigman/12633936/realtime 4,338 +71 1.66%
S&P 500
/quotes/zigman/3870025/realtime 1,865 +36 1.95%
GlobalDow
/quotes/zigman/629063/realtime 2,070 +23 1.11%
Gold
/quotes/zigman/33772884/delayed 1,239 -9 0.75%
Oil
/quotes/zigman/2260836/delayed 29.02 +2.81 10.72%
FTSE 100
/quotes/zigman/3173262/delayed 5,708 +171 3.08%
DAX
/quotes/zigman/2380246/delayed 8,968 +215 2.45%
CAC 40
/quotes/zigman/3173214/delayed 3,995 +98 2.52%
FTSE MIB
/quotes/zigman/1482176/delayed 16,515 +742 4.70%
IBEX 35
/quotes/zigman/2759620/delayed 7,921 +175 2.25%
Stoxx 600
/quotes/zigman/2380150/delayed 312 +9 2.91%
Asia Dow
/quotes/zigman/6959860/realtime 2,385 -51 2.10%
Nikkei 225
/quotes/zigman/5986735/delayed 14,953 -761 4.84%
Hang Seng
/quotes/zigman/2622475/delayed 18,320 -226 1.22%
Shanghai
/quotes/zigman/1859015/delayed 2,763 -18 0.63%
Sensex
/quotes/zigman/1652085/delayed 22,986 +34 0.15%
Singapore
/quotes/zigman/1709939/delayed 2,540 +2 0.07%
Euro
/quotes/zigman/16008136/realtime/sampled 1.13 -0.01 0.61%
Yen
/quotes/zigman/16008150/realtime/sampled 113.25 +0.83 0.74%
Pound
/quotes/zigman/16008140/realtime/sampled 1.45 +0.00 0.18%
Australia$
/quotes/zigman/16008115/realtime/sampled 0.71 0.00 0.04%
DXY Index
/quotes/zigman/1652083/delayed 95.97 +0.36 0.38%
WSJ $ Idx
/quotes/zigman/41508961/realtime 88.99 +0.23 0.26%
U.S. 10yr
/quotes/zigman/15866666/realtime 1.75 0.00 0.00%
German 10y
/quotes/zigman/15866409/realtime 0.26 +0.07 37.97%
Italy 10yr
/quotes/zigman/15866497/realtime 1.64 -0.08 4.67%
Spain 10yr
/quotes/zigman/15866444/realtime 1.74 -0.04 2.01%
U.K. 10yr
/quotes/zigman/15866328/realtime 1.42 0.00 0.00%
Japan 10yr
/quotes/zigman/15866525/realtime 0.08 0.00 0.00%
Crude Oil
/quotes/zigman/2260836/delayed 29 +3 10.72%
Gold
/quotes/zigman/33772884/delayed 1,239 -9 0.75%
Corn
/quotes/zigman/25518691/delayed 359 -1 0.35%
DJIA F
/quotes/zigman/48241424/delayed 15,925 +313 2.00%
S&P F
/quotes/zigman/43106711/delayed 1,860 +36 1.95%
Silver
/quotes/zigman/32655632/delayed 16 0 0.03%

Quotes

Symbol Price Change % Change
FB /quotes/zigman/9962609/composite 102.01 0.10 0.10%
AAPL /quotes/zigman/68270/composite 93.99 0.29 0.31%
GOOG /quotes/zigman/59527964/composite 682.40 -0.71 -0.10%
BAC /quotes/zigman/190927/composite 11.95 0.79 7.08%
C /quotes/zigman/5065548/composite 37.54 2.56 7.32%
F /quotes/zigman/264304/composite 11.55 0.38 3.40%
T /quotes/zigman/398198/composite 36.47 0.26 0.72%
BP /quotes/zigman/247026/composite 29.02 1.38 4.99%
GE /quotes/zigman/227468/composite 28.26 0.81 2.95%
Visit the quote page and your most recently viewed stocks will automatically be displayed here.
Please log in to view your watchlist
MarketWatch Portfolio

World News from MarketWatch

Rates »

5 yr CD
1.3%
2 yr CD
0.7%
1 yr CD
0.6%
MMA $10K+
0.2%
MMA $50K+
0.4%

National averages from Bankrate.com

You Don’t Need Another Credit Card, You Need A Better One.
Avg. APR Last Week 6 Months
Low Interest 11.96% 11.96% 11.62%
Business 13.12% 13.12% 12.85%
Student 13.42% 13.42% 13.14%
Balance Transfer 14.35% 14.35% 14.12%
Airline 15.17% 15.17% 15.10%
Cash Back 15.20% 15.26% 15.27%
Reward 15.25% 15.28% 15.14%
Instant Approval 18.02% 18.21% 18.00%
Bad Credit 22.56% 22.88% 22.73%
Source:CreditCards.com

SPONSORED SECTIONS

Trending Tickers
  • /quotes/zigman/259867/composite RAX+5.19%
  • /quotes/zigman/69765/composite CERN+1.76%
  • /quotes/zigman/333256/composite IYT+2.39%
  • /quotes/zigman/4475302/composite HII+2.23%
  • /quotes/zigman/20919077/composite INDL+3.17%
X
Powered by StockTwits
Link to MarketWatch's Slice.

As of July 2, 2013, the SmartMoney content you loved now lives on MarketWatch.

MarketWatch will continue to provide the same important news and information you rely on every day. And, as a MarketWatch user, you will be able to enjoy:

  • Personalized news and quote email alerts
  • Editorial e-newsletters about personal finance, mutual funds and market-specific coverage
  • Premium newsletters by our market experts
  • Games, such as Virtual Stock Exchange and Beat the Darts
  • Free WSJ.com registration